Edelman Expands Healthcare Marketing Team with Appointment of UK Omnichannel Strategy Director
Edelman has appointed Claudia Aru as UK omnichannel strategy director within its growing healthcare marketing team in London. The hire comes as Edelman continues to diversify its healthcare offer and follows the appointment of Jenni Mercer as UK head of healthcare marketing last year.
Healthcare Marketing is a critical pillar of Edelman鈥檚 healthcare offer, supporting clients to navigate the various challenges presented by increasing competition and market saturation, digital transformation, patient/ customer behaviour shifts, emerging tech such as AI, ROI scrutiny, and evolving omnichannel expectations.
As UK Omnichannel strategy director, Claudia will design and execute strategies that address these pressing industry challenges, while maintaining a steadfast focus on trust and credibility.
Claudia joins Edelman from Inizio Evoke London, where she played a pivotal role, collaborating with leading pharmaceutical companies to create transformative engagement programmes that blended marketing goals with digital innovation. Her experience extends beyond healthcare, having led account-based marketing initiatives for global technology leaders such as AWS, Deloitte, Oracle, Samsung, and HP. Additionally, she has driven impactful campaigns for iconic consumer brands, including PepsiCo and Coca-Cola.
Jenni Mercer, head of UK healthcare marketing at Edelman, commented, 鈥淗ealthcare businesses today face an unprecedented combination of challenges in a landscape where trust is both critical and increasingly complex. At Edelman, we partner with the world鈥檚 most influential healthcare organisations to tackle these issues head-on, delivering strategies that earn trust, and drive action with our audiences. Claudia鈥檚 deep expertise across healthcare and other sectors makes her ideally suited to help our clients navigate this evolving environment and stay ahead of the curve.鈥
In addition to Healthcare Marketing, Edelman鈥檚 healthcare offer spans Regulated Medicine Communications, Global Public Health, Corporate Health, and Policy/Government Affairs, helping clients restore confidence, strengthen stakeholder connections, and drive meaningful impact through innovative strategies.
